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Abstract Peptide therapeutics are of increasing
interest due to their biological specificity. We used
a simple technique to study the efficacy of inducing
peptides into adherent chondrocytes by transiently
permeabilizing the membrane with electric pulses (in
situ electroporation). Mechano-growth factor (MGF)
was selected as a model peptide. FITC-labeled MGF
was added to cultures of adherent primary chondro-
cytes grown on ITO coated glass slides. Cells were
subjected to 3–9 pulses of 175–275 V and evaluated
by flow cytometry. Under optimal conditions, an
electroporation efficiency of close to 50% could be
achieved. This technique can be used to study the
functional domains of intracellular peptides, peptide
inhibition of signal transduction and intracrine-med-
iated effects of peptides in adherent cells.
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Introduction
Biologic drugs, including peptides, antibodies, anti-
sense RNA and siRNA, represent one of the fastest
growing segments of the pharmaceutical industry.
Their administration is challenging due to their poor
stability and the difficulty in penetrating the cell and
nuclear membrane. These drugs, however, are appeal-
ing due to their unsurpassed biological specificity and
activity as well as minimal cytotoxicity. Although
there have been many recent advances in peptide
transport mechanisms including modification of mol-
ecules with cell permeable peptides (Torchilin et al.
2001; Dom et al. 2003) and the development of peptide
nanostructures, there is still a great need for funda-
mental studies in which unmodified peptides can be
easily introduced into adherent cells and their nuclei to
study their mechanism of action. Electroporation is a
well established, versatile technique which transiently
permeabilizes the cell membrane, allowing entry of
peptides, siRNA and DNA vectors. This technique is
available in multiple commercial formats, for in vivo
applications (Swartz et al. 2001) and has been amena-
ble to technological advances and specializations
including in situ electroporation of adherent cells
(Brownell et al. 1997; Firth et al. 1997), electroporation
on electronic chips (Yamauchi et al. 2004), and even
single cell electroporation arrays (Khine et al. 2007). In
situ electroporation has been a particularly relevant
advance for the study of connective tissue cells, as it is
not necessary to disrupt their focal adhesions before
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treatment. The goal of this study was to optimize the
efficiency of in situ electroporation-induced peptide
entry into large populations of mammalian primary
cells grown in adhesion culture.
Mechano-growth factor (MGF) was selected as a
model peptide for these studies because of its putative
intracrine mode of action. MGF is a splice variant of
insulin-like growth factor 1 (IGF-1) (Barton 2006)
whose expression is regulated by dynamic stretch of
muscle tissue. Biologically, MGF renews the myogenic
satellite (stem) pool, thus allowing for subsequent
rounds of muscle repair and hypertrophy (Yang and
Goldspink 2002; Hill and Goldspink 2003; Goldspink
2005). Evidence is accumulating to suggest that MGF
is one of the key trophic agents which protect many
tissues in the body from mechanical-damage and
degeneration by inducing proliferation of stem cells
and repair of over-strained or challenged tissues
(Dluzniewska et al. 2005; Carpenter et al. 2007). MGF
is thought to exert its effect independently of the IGF-1
receptor and, in accordance with a nuclear localization
sequence present in its unique C-terminal domain,
transfection studies reveal that it localizes to the nucleus
(Goldspink 2005). We hypothesized that inducing the
direct entry of MGF into cells/nuclei, could be an
important system in which to study the biological
activity of this peptide. In situ electroporation was used
to deliver pulses of direct current to adherent chondro-
cytes and the uptake of peptide was confirmed by
fluorescence microscopy and flow cytometry.
Materials and methods
In situ electroporation device
The electroporation device used has been described
in the literature (Brownell et al. 1997; Raptis and
Firth 2008) and consists of a stainless steel electrode
connected to a pulse generator, an indium/tin oxide
(ITO)-coated glass slide, and a polydimethylsiloxan
(PDMS) frame (32 9 10 9 0.74 mm) (Fig. 1, right).
The PDMS frame was pressed onto the ITO-coated
glass slide (50 9 50 mm, UQG Optics Ltd) resulting
in a water-tight chamber into which cells were seeded
and culture media could be held. The voltage source
was a function generator (SRS DS345 Synthesized
Function Generator) supplying DC from 0.2–3 V.
This signal was amplified 1250-fold by a high-
voltage amplifier and divided down by a resistive
voltage divider network (Fig. 1, left). This system
was used in conjunction with a capacitive discharge
circuit to produce pulses. The current traveled from
the positive electrode, through the culture media,
cells and ITO glass to the negative electrode. Initial
investigations to determine the optimal electropora-
tion parameters were performed using Lucifer yellow
staining, a strongly fluorescent dye which normally
does not pass the cell membrane. Furthermore, a
scratch in the ITO-coated provided a non-electropo-
rated control area within the same glass slide.
Mechano growth factor (MGF) peptide
The 25 amino acid C-terminal MGF peptide (YQPP
STNKNTKSQRRKGSTFEEHKC) from GenScript,
Inc. was end-labeled with N-terminal fluorescein
isothiocyanate (FITC) and had a purity 90.6%.
Immediately prior to experiments, the peptide was
dissolved in calcium-free DMEM (US Biological) at
0.1 mg/ml. In order to determine if other peptides
translocated to the nucleus, FITC-labelled insulin
(Sigma) was also studied using the same electropor-
ation parameters as MGF.
Cell culture and electroporation
Primary chondrocytes were isolated from the knees
of 6 months old calves using a collagenase and
pronase digestion (Wong et al. 2001) and cultured in
DMEM ? GlutaMax media (Invitrogen) supplemented
with 10% (v/v) fetal bovine serum. Passaged cells
were released with trypsin–EDTA and between 150,
000 and 300,000 cells were seeded onto the PDMS
frame. The glass slide was placed inside a Petri dish
and incubated for 24 h. Prior to electroporation, the
medium was aspirated and the cells gently washed
with calcium-free and serum-free DMEM. This
culture medium was removed and the electrode was
placed on top of the cells, resting on the PDMS
frame. A small hole (about 1 mm2) between each of
the two lower corners of the anode (facing the
cathode) and the PDMS frame allowed the injection
of the electroporation medium (300 ll). The elec-
trode was connected to the capacitive discharge
circuit and the voltage was applied. To identify the
optimal conditions for electroporation of the peptide,
the voltage was varied from 175 to 275 V and
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3–9 pulses were applied. After electroporation, the
electrode was removed and the cells were incubated
in calcium-free media at room temperature for 2 min
to allow the pores to seal. The cells were washed two
times with calcium free DMEM and the cell fluores-
cence was examined with a fluorescence microscope.
Flow cytometry
Flow cytometry acquisition and analysis of the
electroporated chondrocytes were performed on a
FACSAria (BD Biosciences) with a blue (488 nm)
solid state laser (530/30 and 502LP filter) to deter-
mine the percentage of MGF–FITC containing cells.
The cells were trypsinized (800 ll, 25% trypsin/
EDTA, Gibco) and centrifuged. The cell pellet was
resuspended in 500 ml PBS buffer and filtered
through a 50 lm CellTrics filter (Partec). A negative
control sample was used which was treated in the
same way, except the MGF solution was replaced by
calcium-free DMEM. Mean fluorescence intensity
(MFI) was calculated based on the photon flux/time
of each sorted cell, and the start of the gate was
chosen as the point where the highest fluorescence
intensity occured in the negative sample. The ratio of
MFI between each sample and the negative control
was calculated using FlowJo software (ver. 8.8.7).
Results
Fluorescence microscopy revealed that nearly 100%
of the cells had incorporated Lucifer yellow upon
electroporation (Fig. 2a), whereas *30% of the cells
had taken up the MGF–FITC peptide (Fig. 2d) under
the same conditions. No fluorescence was detected in
the non-electroporated controls which were incu-
bated with MGF–FITC (Fig. 2b) and the morphology
of the cells was not visibly effected by the electro-
poration treatment (Fig. 2c). For the Lucifer yellow,
MGF and insulin (not shown), the fluorescence was
strongest in the nuclei of the cells, indicating the
molecules had passed through the cell and nuclear
membranes.
Figure 3 describes the flow cytometry results
showing the dependence of fluorescence intensity
factor on cell density and the applied voltage. With
three pulses, the highest fluorescence intensity factor
(7.2) was with 150,000 cells 225 V, with the scatter
plot showing a clear delineation of this population of
cells based on their fluorescence intensity (Fig. 3). In
experiments in which the pulse number was varied,
the highest percentage of fluorescing cells was with
six pulses (46%).
Figure 4 shows the increased incidence of fluo-
rescing cells as well as their higher fluorescence
intensity after electroporation with increasing pulse
number. The shift in the intensity curve demon-
strated that cells exhibited greater fluorescent inten-
sity with six pulses. Applications of nine pulses
decreased the cell viability reflecting a ‘‘burning’’ of
the cells on the ITO glass slides. The flow cytometry
revealed only 5.6% cells were positively labelled
in non-electroporated controls, indicating that the
peptide entry was largely mediated by membrane
electropermeabilization.
Fig. 1 Left: Electrical circuit. In charge mode, the divider
network (2, 1 MOhm) divides the input voltage by three and
charges the capacitance (94 nF) over the switch. When the
switch is thrown, the system changes to discharge mode and
the capacitance is discharged over the load (electrode-cell-slide
complex, *2 MOhm). Right: In situ electroporation device
modified from Raptis and colleagues: 1 glass slide, 2 ITO
layer, 3 negative electrode, 4 positive electrode, 5 holder, 6
PDMS frame, 7 adherent cells with electroporation medium
Biotechnol Lett (2011) 33:883–888 885
123
Discussion
In situ electroporation is a simple, effective method for
introducing peptides into large numbers of adherent
cells. One major advantage of this technique over
conventional electroporation is that it is not necessary
to release the cells from their substrate using proteo-
lytic digestion, a process that damages cells and
disrupts their native cell–cell and cell–substrate adhe-
sions. Maintaining functional connection with the
Fig. 2 a Adherent
chondrocytes electroporated
with Lucifer yellow at
optimal conditions (225 V,
150,000 cells, 3 pulses).
b Cells incubated with
MGF–FITC in the absence
of electroporation showing
no fluorescence. Bright field
(c) and fluorescence
(d) image of cells
electroporated in the
presence of MGF–FITC.
Stars in (c) mark the four
cells in (d) showing uptake
of MGF–FITC. Scale bar is
50 microns
Fig. 3 Left: Fluorescence
intensity factor versus cell
number for the three
voltages studied. Right:
Scatter plot of fluorescence
versus side scatter
(150,000 cells/well) for
electroporation with MGF–
FITC at 275 V (orange),
225 V (green), 175 V
(blue) and with serum-free
DMEM (red). Number of
sorted cells were 2580,
3030, 2610 and 2445
respectively
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substrate and other cells is important given recent
evidence showing that cytoskeletal disruption inhibits
normal biochemical signaling via the nucleus (Nelson
and Nusse 2004). Normally, adherent cells, while in
suspension, might not be sensitive to the immediate
effects of introduced biologically active peptides.
Furthermore, cytoplasmic-nuclear traffiking requires
cytoskeletal integrity. Finally, regions of electropora-
ted and non-electroporated cells can be examined in
adjacent regions depending on the patterning of the
conductive substrate.
In our system the optimal conditions for electro-
poration was at 225 V, with six pulses and 150,000
cells/well. One possible reason for the lower electro-
poration efficiency above 150,000 cells/well could be
that the current flows through a greater number of
cells per given area of substrate, thereby effectively
reducing the potential that each cell experiences.
Lower than 225 V, it is likely that fewer cells reach
the threshold value for membrane permeabilization.
The decrease in the number of fluorescent cells at
higher voltages (275 V) could be related to the fact
that higher voltages might damage cells. It is
important to note, that these conditions have been
optimized for one cell type and the optimal param-
eters for other cell types might differ.
Further development of the in situ electroporation
technique described here will focus on the transfection
of plasmid DNA and siRNA. Yamauchi et al. (2004,
2005) used layer-by-layer assembly of poly(ethylenei-
mine) and plasmid DNA to coat ITO-electrodes and
could obtain temporal spatial control of plasmid vector
expression upon application of electric pulses. For a
spatially specific parallel transfer of multiple genes,
they further developed a small interfering RNA
(siRNA) microarray (Fujimoto et al. 2008). This
system uses the base-pairing properties of nuclei acids
by adding labeled RNA molecules to single DNA spots
resulting in spatially-specific gene silencing (Fujimoto
et al. 2006).
The results of this study illustrate the versatility of
using in situ electroporation to investigate diverse
biological processes. Here we show that peptides,
which typically do not enter the cytosol (MGF), can be
induced to do so using in situ electroporation. Other
peptides, such as insulin, readily enter the nucleus
(Goldfine et al. 1977) both with and without electro-
poration. Our initial results and those of others suggest
that in situ electroporation of DNA is useful for the
spatial and temporal control of protein expression, or
silencing of targeted genes.
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